Results 231 to 240 of about 3,006,184 (303)

Kinase drug discovery approaches in chronic myeloproliferative disorders

Oncogene, 2009
C. Kumar, A. Purandare, FY Lee, MV Lorenzi   +3 more
semanticscholar   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Blood signals: from birth to disease and death

, 2014
Bowman, T., Flores-Figueroa, E., King, K., Kokkaliaris, K., Lessard, J., Trompouki, E., Will, B.   +6 more
core   +1 more source

Back to biology: new insights on inheritance in myeloproliferative disorders. [PDF]

Curr Hematol Malig Rep, 2014
Braunstein EM, Moliterno AR.
europepmc   +1 more source

NPV-BSK805, an Antineoplastic Jak2 Inhibitor Effective in Myeloproliferative Disorders, Causes Adiposity in Mice by Interfering With the Action of Leptin. [PDF]

Front Pharmacol, 2018
Haissaguerre M, Ferriere A, Clark S, Guzman-Quevedo O, Tabarin A, Cota D.   +5 more
europepmc   +1 more source

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.

Blood, 2009
G. Piaggio, V. Rosti, M. Corselli, F. Bertolotti, G. Bergamaschi, S. Pozzi, D. Imperiale, Barbara Chiavarina, E. Bonetti, F. Novara, M. Sessarego, L. Villani, A. Garuti, M. Massa, R. Ghio, R. Campanelli, A. Bacigalupo, A. Pecci, G. Viarengo, O. Zuffardi, F. Frassoni, G. Barosi   +21 more
semanticscholar   +1 more source

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders. [PDF]

Arch Med Sci, 2017
Ozdemirkiran FG, Nalbantoglu S, Gokgoz Z, Payzin BK, Vural F, Cagirgan S, Berdeli A.   +6 more
europepmc   +1 more source

Overcoming the problem of pseudohypoxemia in myeloproliferative disorders: Another trick in the bag

, 2012
K. N. Prasad, Manjunath Prabhu, Leena M. Priya, Sanjay Sasikumar   +3 more
openalex   +1 more source

JAK2 mutasyonlarının Kronik Miyeloproliferatif hastalık ayırıcı tanısındaki önemi : The importance of JAK2 mutations in distinctive diagnosis of chronic myeloproliferative disorders

, 2010
Güven Yenmiş
openalex   +1 more source

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

Blood, 2008
P. Beer, P. Campbell, L. Scott, A. Bench, W. Erber, D. Bareford, B. Wilkins, J. Reilly, H. Hasselbalch, R. Bowman, K. Wheatley, G. Buck, C. Harrison, A. Green   +13 more
semanticscholar   +1 more source